Mechanisms of Exercise & Estrogen Induced Cytoprotection
运动机制
基本信息
- 批准号:7367007
- 负责人:
- 金额:$ 9.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-04-01 至 2010-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAgeAlternative TherapiesApoptosisApoptoticAttenuatedCardiac MyocytesCardiovascular DiseasesCell DeathCell HypoxiaCellsClinicalClinical TrialsCoronary arteryCytoprotectionDisease ProgressionEndothelial CellsEqual ProtectionEstrogen Replacement TherapyEstrogen ReplacementsEstrogen TherapyEstrogensExerciseFemaleFunctional disorderGenderHeartHeart DiseasesHypoxiaIn VitroIncidenceInfarctionInjuryInterventionIschemiaLigationMediatingModelingMyocardialMyocardial InfarctionMyocardial IschemiaMyocardial StunningNecrosisPerformancePersonal SatisfactionPhysiological reperfusionPostmenopausePremenopausePublishingRattusReperfusion InjuryReperfusion TherapyResearchRiskSex CharacteristicsSignal TransductionTrainingVascular Endothelial CellVascular EndotheliumVery Light ExerciseWomanWorkcardiovascular disorder riskimprovedin vivo Modelinhibitor/antagonistinterestmalemenmortalityprotective effectsedentarysize
项目摘要
DESCRIPTION (provided by applicant):
While recent clinical trials have prompted an important reevaluation of estrogen therapy, the majority of evidence suggests that the post-menopausal heightened risk of mortality from heart disease may be attenuated by estrogen, resulting in a 40-50% decrease in the incidence of heart disease. Nonetheless, given the potential for accelerated disease progression associated with estrogen replacement in some women, investigating alternative interventions for protecting against the post-menopausal increase in mortality from heart disease is of great interest. One potential alternative therapy for decreasing the risk of mortality from ischemic heart disease is endurance exercise. It is well established that exercise improves tolerance to myocardial ischemia and reperfusion. Endurance exercise improves contractile performance and attenuates infarction size. The mechanism(s) to explain the cardioprotective effect of exercise remain elusive. Estrogen and exercise appear to exert similar cardioprotective effects and estrogen has been shown to do so via protection of both cardiac myocytes and vascular endothelial cells. The proposed research will further our understanding of mechanisms of exercise and estrogen-induced cardioprotection by addressing: (1) whether the protective effects of exercise are targeted at cardiomyocytes versus vascular endothelium, (2) if exercise protects cardiomyocytes and endothelial cells against apoptotic versus necrotic cell death, (3) whether exercise-mediated protection is dependent on estrogen (i.e., whether exercise protects similarly pre- and post-menopause and whether exercise-induced protection is gender-dependent), and (4) if exercise and estrogen facilitate cardioprotection via NFkB-mediated signaling. These aims will be addressed using cardiac myocytes and aortic endothelial cells isolated from exercised rats, employing specific pharmacological inhibitors. These studies will improve our understanding of the mechanisms of exercise-induced cytoprotection, perhaps leading to alternative therapies for decreasing mortality from heart disease.
描述(由申请人提供):
虽然最近的临床试验促使人们对雌激素治疗进行重要的重新评估,但大多数证据表明,雌激素可能会降低绝经后心脏病死亡率升高的风险,从而使心脏病发病率降低 40-50% 。 尽管如此,考虑到一些女性与雌激素替代相关的疾病加速进展的可能性,研究防止绝经后心脏病死亡率增加的替代干预措施非常有意义。 降低缺血性心脏病死亡风险的一种潜在替代疗法是耐力运动。 众所周知,运动可以改善心肌缺血和再灌注的耐受性。 耐力运动可以改善收缩性能并减少梗塞面积。 解释运动的心脏保护作用的机制仍然难以捉摸。 雌激素和运动似乎具有相似的心脏保护作用,雌激素已被证明是通过保护心肌细胞和血管内皮细胞来实现这一作用的。 拟议的研究将通过解决以下问题进一步了解运动和雌激素诱导的心脏保护机制:(1)运动的保护作用是否针对心肌细胞与血管内皮,(2)运动是否可以保护心肌细胞和内皮细胞免受凋亡与坏死的影响细胞死亡,(3)运动介导的保护是否依赖于雌激素(即运动是否对绝经前和绝经后具有类似的保护作用,以及运动引起的保护是否性别依赖性),以及(4)运动和雌激素是否通过 NFkB 介导的信号传导促进心脏保护。 这些目标将通过使用从运动大鼠中分离的心肌细胞和主动脉内皮细胞并采用特定的药理学抑制剂来实现。 这些研究将增进我们对运动诱导的细胞保护机制的理解,或许会带来降低心脏病死亡率的替代疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Karyn L Hamilton其他文献
Karyn L Hamilton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Karyn L Hamilton', 18)}}的其他基金
Dual treatment of sarcopenia and osteoarthritis with a Nrf2 activator
使用 Nrf2 激活剂双重治疗肌肉减少症和骨关节炎
- 批准号:
9535030 - 财政年份:2017
- 资助金额:
$ 9.73万 - 项目类别:
Dual treatment of sarcopenia and osteoarthritis with a Nrf2 activator
使用 Nrf2 激活剂双重治疗肌肉减少症和骨关节炎
- 批准号:
9386048 - 财政年份:2017
- 资助金额:
$ 9.73万 - 项目类别:
Assessment of proteostasis in cultured fibroblasts of short and long-lived species
短寿命和长寿命物种培养成纤维细胞中蛋白质稳态的评估
- 批准号:
9068513 - 财政年份:2016
- 资助金额:
$ 9.73万 - 项目类别:
Translational mechanisms of mitochondrial protein synthesis
线粒体蛋白质合成的翻译机制
- 批准号:
8504625 - 财政年份:2013
- 资助金额:
$ 9.73万 - 项目类别:
Translational mechanisms of mitochondrial protein synthesis
线粒体蛋白质合成的翻译机制
- 批准号:
8669900 - 财政年份:2013
- 资助金额:
$ 9.73万 - 项目类别:
Translational mechanisms of mitochondrial protein synthesis
线粒体蛋白质合成的翻译机制
- 批准号:
9017902 - 财政年份:2013
- 资助金额:
$ 9.73万 - 项目类别:
相似国自然基金
HTRA1介导CTRP5调控脂代谢通路在年龄相关性黄斑变性中的致病机制研究
- 批准号:82301231
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PLAAT3降低介导线粒体降解异常在年龄相关性白内障发病中的作用及机制
- 批准号:82301190
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
跨尺度年龄自适应儿童头部模型构建与弥漫性轴索损伤行为及表征研究
- 批准号:52375281
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
ALKBH5通过SHP-1调控视网膜色素上皮细胞铁死亡在年龄相关性黄斑变性中的作用机制研究
- 批准号:82301213
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
叶黄素调控脂代谢紊乱所致年龄相关性黄斑病变的血-视网膜屏障损伤机制研究
- 批准号:82373570
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Developing a novel disease-targeted anti-angiogenic therapy for CNV
开发针对 CNV 的新型疾病靶向抗血管生成疗法
- 批准号:
10726508 - 财政年份:2023
- 资助金额:
$ 9.73万 - 项目类别:
Novel risk stratification score for patients presenting with acute Cerebral Venous Sinus Thrombosis
急性脑静脉窦血栓形成患者的新风险分层评分
- 批准号:
10592974 - 财政年份:2023
- 资助金额:
$ 9.73万 - 项目类别:
Understanding the regulation of the intestinal epithelium in Alzheimer’s disease by commensal bacteria and the role it plays in preventing neurocognitive decline
了解共生细菌对阿尔茨海默病肠上皮的调节及其在预防神经认知衰退中的作用
- 批准号:
10680057 - 财政年份:2023
- 资助金额:
$ 9.73万 - 项目类别:
Diagnostic and treatment landscape of pyoderma gangrenosum
坏疽性脓皮病的诊治现状
- 批准号:
10732688 - 财政年份:2023
- 资助金额:
$ 9.73万 - 项目类别:
Discovery of Cell-based Chemical Probes Targeting Aberrant Angiogenesis in the Eye
发现针对眼部异常血管生成的基于细胞的化学探针
- 批准号:
10453044 - 财政年份:2022
- 资助金额:
$ 9.73万 - 项目类别: